Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$114.22 - $140.1 $42,946 - $52,677
376 Added 2.77%
13,950 $1.93 Million
Q4 2023

Feb 07, 2024

BUY
$75.49 - $124.16 $19,929 - $32,778
264 Added 1.98%
13,574 $1.68 Million
Q3 2023

Nov 14, 2023

BUY
$86.06 - $137.93 $6,282 - $10,068
73 Added 0.55%
13,310 $1.24 Million
Q1 2023

May 09, 2023

BUY
$104.0 - $122.92 $25,168 - $29,746
242 Added 1.86%
13,237 $1.54 Million
Q4 2022

Feb 08, 2023

SELL
$84.98 - $122.67 $81,665 - $117,885
-961 Reduced 6.89%
12,995 $1.47 Million
Q3 2022

Nov 07, 2022

BUY
$76.35 - $94.18 $31,914 - $39,367
418 Added 3.09%
13,956 $1.12 Million
Q2 2022

Aug 08, 2022

BUY
$67.99 - $132.89 $692,138 - $1.35 Million
10,180 Added 303.16%
13,538 $1.2 Million
Q1 2022

May 09, 2022

SELL
$94.08 - $130.2 $206,787 - $286,179
-2,198 Reduced 39.56%
3,358 $1.72 Million
Q4 2021

Feb 08, 2022

BUY
$129.87 - $162.82 $17,792 - $22,306
137 Added 2.53%
5,556 $2.35 Million
Q3 2021

Nov 09, 2021

BUY
$106.71 - $143.18 $4,375 - $5,870
41 Added 0.76%
5,419 $3.38 Million
Q2 2021

Aug 13, 2021

BUY
$80.99 - $107.93 $25,997 - $34,645
321 Added 6.35%
5,378 $2.78 Million
Q1 2021

May 14, 2021

SELL
$84.79 - $104.74 $23,402 - $28,908
-276 Reduced 5.18%
5,057 $1.82 Million
Q4 2020

Feb 10, 2021

BUY
$78.0 - $104.5 $7,020 - $9,405
90 Added 1.72%
5,333 $1.97 Million
Q3 2020

Nov 13, 2020

BUY
$95.51 - $112.95 $10,697 - $12,650
112 Added 2.18%
5,243 $2.16 Million
Q2 2020

Aug 12, 2020

BUY
$62.68 - $105.34 $67,819 - $113,977
1,082 Added 26.72%
5,131 $2.08 Million
Q1 2020

Apr 20, 2020

BUY
$47.79 - $75.63 $193,501 - $306,225
4,049 New
4,049 $1.09 Million
Q3 2018

Nov 13, 2018

SELL
$23.35 - $36.72 $106,476 - $167,443
-4,560 Closed
0 $0
Q2 2018

Aug 02, 2018

BUY
$17.54 - $25.22 $79,982 - $115,003
4,560 New
4,560 $291,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $26.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Altman Advisors, Inc. Portfolio

Follow Altman Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altman Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Altman Advisors, Inc. with notifications on news.